Skip to content

Gross margin at other companies

Baxter International logo
Baxter InternationalBAX
30.1%-5.9pp
Boston Scientific logo
Boston ScientificBSX
69.2%+0.5pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
48.7%+0.9pp
Medtronic logo
MedtronicMDT
65%-0.3pp
Abbott logo
AbbottABT
56.3%+0.4pp
ICU Medical logo
ICU MedicalICUI
37.9%+2.8pp

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.44B+16.0%
Enterprise value$3.27B+21.8%
P/S4.4×-0.4×

Profitability

See full
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's gross margin?
iRhythm Holdings, Inc. (IRTC) reported gross margin of 71% in Q1 2026.
How has iRhythm Holdings, Inc. 's gross margin changed year-over-year?
iRhythm Holdings, Inc. 's gross margin increased by 2.3% year-over-year, from 69.4% to 71%.
What is the long-term trend for iRhythm Holdings, Inc. 's gross margin?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's gross margin has grown at a -0.8% compound annual growth rate (CAGR), from 73.5% to 70.6%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.